Paul Tawa
Papers
1
Total Citations
3
H-Index
1
About
Paul Tawa is a researcher whose work has centered on the molecular mechanisms of apoptosis, particularly the role of caspase-3 in programmed cell death. His most notable contribution comes from a 2005 study that developed a novel active-caspase-3 enzyme-linked immunosorbent assay (ELISA) to quantitatively correlate fractional caspase-3 inhibition with apoptotic markers in NT2 cells. This work provided a critical methodological advance for precisely measuring caspase-3 activity in cellular models, offering a more nuanced understanding of how partial inhibition of this key executioner caspase impacts downstream apoptotic events. While his publication record reflects a focused, specialized contribution to cell biology, Tawa’s assay design has been cited in subsequent research exploring caspase regulation and therapeutic interventions for neurodegenerative and cancer-related apoptosis. His approach underscores the importance of correlating enzymatic activity with phenotypic outcomes, a principle that remains relevant for researchers studying cell death pathways. Though his citation count is modest, Tawa’s work represents a careful, foundational step in linking biochemical inhibition to cellular fate, demonstrating the value of precise quantitative tools in apoptosis research.
Research Focus
Key Achievements
Top Papers
- 1